189 related articles for article (PubMed ID: 16247466)
1. MCM7 amplification and overexpression are associated with prostate cancer progression.
Ren B; Yu G; Tseng GC; Cieply K; Gavel T; Nelson J; Michalopoulos G; Yu YP; Luo JH
Oncogene; 2006 Feb; 25(7):1090-8. PubMed ID: 16247466
[TBL] [Abstract][Full Text] [Related]
2. Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma.
Shohet JM; Hicks MJ; Plon SE; Burlingame SM; Stuart S; Chen SY; Brenner MK; Nuchtern JG
Cancer Res; 2002 Feb; 62(4):1123-8. PubMed ID: 11861392
[TBL] [Abstract][Full Text] [Related]
3. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis.
Honeycutt KA; Chen Z; Koster MI; Miers M; Nuchtern J; Hicks J; Roop DR; Shohet JM
Oncogene; 2006 Jul; 25(29):4027-32. PubMed ID: 16518415
[TBL] [Abstract][Full Text] [Related]
4. A 'DNA replication' signature of progression and negative outcome in colorectal cancer.
Pillaire MJ; Selves J; Gordien K; Gourraud PA; Gentil C; Danjoux M; Do C; Negre V; Bieth A; Guimbaud R; Trouche D; Pasero P; Méchali M; Hoffmann JS; Cazaux C
Oncogene; 2010 Feb; 29(6):876-87. PubMed ID: 19901968
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of prostate cancer growth and metastasis using small interference RNA specific for minichromosome complex maintenance component 7.
Shi YK; Yu YP; Tseng GC; Luo JH
Cancer Gene Ther; 2010 Oct; 17(10):694-9. PubMed ID: 20539323
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
[TBL] [Abstract][Full Text] [Related]
7. Minichromosome maintenance proteins 2, 3 and 7 in medulloblastoma: overexpression and involvement in regulation of cell migration and invasion.
Lau KM; Chan QK; Pang JC; Li KK; Yeung WW; Chung NY; Lui PC; Tam YS; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
Oncogene; 2010 Oct; 29(40):5475-89. PubMed ID: 20661220
[TBL] [Abstract][Full Text] [Related]
8. Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancer.
Ruiz C; Holz DR; Oeggerli M; Schneider S; Gonzales IM; Kiefer JM; Zellweger T; Bachmann A; Koivisto PA; Helin HJ; Mousses S; Barrett MT; Azorsa DO; Bubendorf L
J Pathol; 2011 Mar; 223(4):543-52. PubMed ID: 21294127
[TBL] [Abstract][Full Text] [Related]
9. KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer.
Bloch M; Ousingsawat J; Simon R; Schraml P; Gasser TC; Mihatsch MJ; Kunzelmann K; Bubendorf L
Oncogene; 2007 Apr; 26(17):2525-34. PubMed ID: 17146446
[TBL] [Abstract][Full Text] [Related]
10. The significance of LMO2 expression in the progression of prostate cancer.
Ma S; Guan XY; Beh PS; Wong KY; Chan YP; Yuen HF; Vielkind J; Chan KW
J Pathol; 2007 Feb; 211(3):278-85. PubMed ID: 17167821
[TBL] [Abstract][Full Text] [Related]
11. MCM7 interacts with androgen receptor.
Shi YK; Yu YP; Zhu ZH; Han YC; Ren B; Nelson JB; Luo JH
Am J Pathol; 2008 Dec; 173(6):1758-67. PubMed ID: 18988800
[TBL] [Abstract][Full Text] [Related]
12. Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo.
Shukeir N; Pakneshan P; Chen G; Szyf M; Rabbani SA
Cancer Res; 2006 Sep; 66(18):9202-10. PubMed ID: 16982764
[TBL] [Abstract][Full Text] [Related]
13. Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer.
Singh LS; Berk M; Oates R; Zhao Z; Tan H; Jiang Y; Zhou A; Kirmani K; Steinmetz R; Lindner D; Xu Y
J Natl Cancer Inst; 2007 Sep; 99(17):1313-27. PubMed ID: 17728215
[TBL] [Abstract][Full Text] [Related]
14. Low-level TOP2A amplification in prostate cancer is associated with HER2 duplication, androgen resistance, and decreased survival.
Murphy AJ; Hughes CA; Barrett C; Magee H; Loftus B; O'Leary JJ; Sheils O
Cancer Res; 2007 Mar; 67(6):2893-8. PubMed ID: 17363613
[TBL] [Abstract][Full Text] [Related]
15. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
17. Evolution of the androgen receptor pathway during progression of prostate cancer.
Hendriksen PJ; Dits NF; Kokame K; Veldhoven A; van Weerden WM; Bangma CH; Trapman J; Jenster G
Cancer Res; 2006 May; 66(10):5012-20. PubMed ID: 16707422
[TBL] [Abstract][Full Text] [Related]
18. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.
Armstrong AP; Miller RE; Jones JC; Zhang J; Keller ET; Dougall WC
Prostate; 2008 Jan; 68(1):92-104. PubMed ID: 18008334
[TBL] [Abstract][Full Text] [Related]
19. Human INT6 interacts with MCM7 and regulates its stability during S phase of the cell cycle.
Buchsbaum S; Morris C; Bochard V; Jalinot P
Oncogene; 2007 Aug; 26(35):5132-44. PubMed ID: 17310990
[TBL] [Abstract][Full Text] [Related]
20. Expression of prothymosin alpha is correlated with development and progression in human prostate cancers.
Suzuki S; Takahashi S; Takahashi S; Takeshita K; Hikosaka A; Wakita T; Nishiyama N; Fujita T; Okamura T; Shirai T
Prostate; 2006 Apr; 66(5):463-9. PubMed ID: 16353248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
